NEW

KA Imaging Launching Portable Dual-Energy X-ray Detector

For the first time, practitioners will be able to leverage dual-energy X-ray technology in a portable system. Canadian manufacturer KA Imaging is getting ready to launch Reveal, the world’s first dual-energy X-ray detector that can be taken to the bedside. “Due to...

CereHealth Showcases “Going Against the Norm” During the Society of Nuclear Medicine and Molecular Imaging’s Annual Meeting

CereHealth Corp., a recognized leader and innovator in biotechnology applications and advanced neurodiagnostics, announced that its FDA-cleared population template, an alternative to traditional normative datasets for quantitative analysis of clinical brain SPECT,...

VA Selects Philips to Create World’s Largest Tele-Critical Care System

Royal Philips has announced that the U.S. Department of Veterans Affairs (VA) has awarded a contract to Philips to expand VA’s tele-critical care program, creating the world’s largest system to provide veterans remote access to intensive care expertise, regardless of...

Hologic Launches Cart-Based Ultrasound System

Hologic Inc. has announced the U.S. launch of the SuperSonic MACH 40 ultrasound system, expanding the company’s suite of ultrasound technologies with its first premium, cart-based system. The new system features excellent image quality, standard-setting imaging modes...

Eon Continues Momentum Across the US as the 75th Facility Goes Live with Denver Based Start Up

EonDirect, the leading Early Lung Cancer Identification Management Platform, announces the Go-Live of St Peter’s Health in Helena, MT.

DENVER and HELENA, Mont., Aug. 22, 2019 /PRNewswire/ — Eon announced today the successful implementation and Go-Live of EonDirect at St. Peter’s Health in Helena, MT earlier this month. St. Peter’s chose EonDirect over other market solutions because of Eon’s innovative approach and technical superiority. EonDirect went live at a total of fourteen facilities during the months of June and July, with an additional 16 more slated to go live in September.

EonDirect identifies and ensures longitudinal tracking of both lung screening and incidentally identified pulmonary nodule patients through the care continuum. The journey begins with an initial LDCT screen or Chest CT and continues through either serial surveillance or further diagnostic workups. By tracking patients from diagnosis through treatment, the growth of the program and it’s community health impact can be analyzed, as well as improving morbidity and mortality.

Roughly 400 patients are now part of St. Peter’s screening and pulmonary incidental program and their early experience with EonDirect shows:

162 lung cancer screening patient data have been brought into 100% compliance and re-submitted to the LCSR.
236 patients have been positively identified with incidental nodules and registered to the EonDirect dashboard for longitudinal tracking.
The significance of the identification of the incidental pulmonary nodules means 236 more patients, who most likely would have gone unfollowed, will now be followed and managed through St. Peter’s lung team. While hospitals have invested millions into expensive electronic medical record (EMR) systems, they have no ability to flag and manage incidental nodule patients. EonEndu is Eon’s patient identification and data extraction deep learning engine. It “reads” radiology exams to identify incidental findings with a positive predictive value over 90%. Once identified, these patients are registered to the EonDirect dashboard to be tracked – benefitting both the patient and hospitals.

EonDirect was created by a practicing interventional pulmonologist, Aki Alzubaidi, DO, FCCP. Aki understood the need for screening and incidental pulmonary nodule identification and patient tracking without disrupting current clinical workflow. In addition, EonDirect facilitates automatic data entry of lung cancer screening required registry fields to the American College of Radiology’s (ACR) Lung Cancer Screening Registry (LCSR). With a focus on reducing manual data entry, Eon’s deep learning models ensure facilities are 100% compliant with the Centers for Medicare and Medicaid Services (CMS) requirements for lung cancer screening. Because of the burdensome requirements placed on lung screening programs by CMS and the ACR, no facility that Eon has worked with has been 100% compliant prior to using Eon.

The St. Peter’s Health Go-Live marks the 31st state EonDirect is now live in. Seventy-five facilities across the country utilize EonDirect, ranging from rural community hospitals like St. Peter’s, to top academic centers and multi-hospital integrated delivery networks (IDNs). These institutions use EonDirect to identify more incidental nodule patients and ensure follow up care, while streamlining processes for their lung cancer screening (LCS) programs. Eon will be contracted with 200 hospitals this year and will be live in 160 facilities by December, 2019.

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *